Compare VYNE & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYNE | MLSS |
|---|---|---|
| Founded | 2003 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 22.1M |
| IPO Year | 2017 | 1996 |
| Metric | VYNE | MLSS |
|---|---|---|
| Price | $0.61 | $0.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 138.7K | ★ 996.3K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,973,982.00 |
| Revenue This Year | N/A | $12.64 |
| Revenue Next Year | N/A | $8.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.99 |
| 52 Week Low | $0.29 | $0.22 |
| 52 Week High | $1.98 | $1.11 |
| Indicator | VYNE | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 52.85 | 47.90 |
| Support Level | $0.56 | $0.27 |
| Resistance Level | $0.75 | $0.30 |
| Average True Range (ATR) | 0.02 | 0.02 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 68.54 | 38.04 |
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.